Tag: #FetuinA

IntroductionCardiovascular diseases are a leading cause of mortality among patients with end-stage kidney disease (ESKD), particularly those undergoing maintenance hemodialysis (MHD). One potential contributing factor is cardiovascular calcification (CVC), which includes both vascular and valvular calcification. Fetuin-A, a liver-derived glycoprotein known to inhibit calcium-phosphate deposition, has been hypothesized to play a role in preventing these…